Want to join the conversation?
$AMGN's immunotherapy blockbuster Enbrel, delivered 30% growth in 3Q15 due to net selling price. Sensiper, a thyroid drug, grew 29%, driven by inventory, net selling price and unit growth in US and Europe. Prolia, a bone-strengthening drug, grew 25%. XGEVA, a drug for treating Giant Cell Tumor Of Bone, grew 19%.
Any idea why some investors are happy about the disastrous $UA results??
Wow! GM killed it with earnings today! Did not expect this after $F gave the feeling it will eclipse the Chevy maker completely!
Oil rebound starting to show up in energy stocks. $XOM $CVX
I have a feeling "CLOUDy" days are ahead, with $AMZN leading the pack.
$AAL is giving pay hikes to its employees but investors are sulking.